Hercules Capital Inc Stock Price, News & Analysis

Hercules Capital (HTGC) has declared a total cash distribution of $0.48 per share for Q3 2024, consisting of a $0.40 base distribution and an $0.08 supplemental distribution. The distribution will be paid on November 20, 2024, to stockholders of record as of November 13, 2024. The company maintains a variable distribution policy targeting 90-100% of quarterly taxable income. For Q3 2024, 100% of distributions were derived from current earnings and profits, with 80.08% qualifying as Qualified Interest Income for foreign accounts.

Hercules Capital (NYSE: HTGC), the largest specialty financing provider for innovative venture, growth, and established stage companies, has announced the date for its third quarter 2024 financial results release and conference call. The company will release its financial results after market close on Wednesday, October 30, 2024, followed by a conference call at 2:00 p.m. PT (5:00 p.m. ET) on the same day.

To participate in the call, interested parties must register to receive the dial-in number and a unique PIN. A live webcast of the conference call will be available on the investor relations section of Hercules Capital's website. An archived webcast replay will remain accessible on the company's website for at least 30 days following the call.

Hercules Capital, Inc. (NYSE: HTGC) has received a reaffirmed Baa3 investment grade credit and corporate rating from Moody's Investors Service, with a revised outlook to positive from stable. This rating reflects Hercules' strong long-term operating history, internally managed structure, and differentiated venture and growth stage lending model.

The positive outlook is based on expectations of resilient performance despite elevated sector risks, supported by Hercules' focus on senior secured investments, sound underwriting, and effective asset allocation. Moody's anticipates Hercules will maintain superior profitability compared to peers, manage leverage below 1.25x debt-to-equity, and improve its funding and liquidity profile.

Hercules Capital (NYSE: HTGC), the largest specialty financing provider to innovative venture, growth, and established stage companies, has announced its participation in an upcoming financial community event. The company's executive management team will be attending the KBW 2024 BDC Midtown March in New York, NY on Wednesday, October 2, 2024.

Hercules Capital, backed by leading venture capital and select private equity firms, offers financing solutions to companies at various stages of development. Interested parties can arrange meetings with Hercules management through KBW.

Hercules Capital (NYSE: HTGC) has received a BBB+ investment grade corporate rating reaffirmation from Kroll Bond Rating Agency (KBRA). This rating underscores Hercules' strong 20-year operating record and validates its differentiated business model in specialty financing for innovative venture, growth, and established stage companies.

The BBB+ rating reflects Hercules' diversified investment portfolio, focusing on senior secured first lien venture debt investments in technology and life sciences sectors. It also highlights the company's solid credit quality, robust risk management, and experienced investment team. KBRA's affirmation is supported by Hercules' proven access to capital markets, diversified funding mix, and high proportion of unsecured debt, providing solid protection for noteholders.

Hercules Capital (NYSE: HTGC) reported strong financial results for Q2 2024. The company achieved record total investment income of $125.0 million, up 7.5% year-over-year, and net investment income (NII) of $82.4 million, or $0.51 per share, an 8.8% increase year-over-year. Q2 saw total gross debt and equity commitments of $686.5 million and record gross fundings of $461.5 million, up 28.7% year-over-year. Hercules maintained a conservative balance sheet with net GAAP leverage of 93.3% and net regulatory leverage of 83.9%. The company's assets under management grew to approximately $4.6 billion, a 14.7% increase year-over-year. Hercules also reported an undistributed earnings spillover of $145.0 million, or $0.89 per ending shares outstanding.

Hercules Capital (NYSE: HTGC) has declared a total cash distribution of $0.48 per share for the second quarter of 2024. This distribution comprises a $0.40 per share base distribution and an $0.08 per share supplemental distribution. The record date is set for August 13, 2024, with the payment date on August 20, 2024.

Hercules maintains a variable distribution policy, aiming to distribute 90% to 100% of its taxable quarterly income. The Board may also pay additional supplemental distributions to distribute approximately all annual taxable income in the year earned. For the quarter ended June 30, 2024, 100% of the distributions were derived from current and accumulated earnings and profits. Additionally, 80.74% of the distributions qualify as Qualified Interest Income (QII), which may be exempt from U.S. withholding tax on foreign accounts.

Hercules Capital (NYSE: HTGC), the largest specialty financing provider for innovative venture, growth, and established stage companies, has announced its second quarter 2024 financial results conference call. The call is scheduled for Thursday, August 1, 2024, at 2:00 p.m. PT (5:00 p.m. ET), with financial results to be released after market close on the same day.

Participants can register for telephone access, and a live webcast will be available on the investor relations section of the company's website at investor.htgc.com. An archived webcast replay will be accessible for at least 30 days following the conference call.

Hercules Capital (NYSE: HTGC) has received approval from the U.S. Small Business Administration (SBA) for its fourth Small Business Investment Company (SBIC) license. This approval grants Hercules access to an additional $175.0 million in long-term debentures, increasing its total borrowing capacity through the SBIC program to $350.0 million.

The SBIC program has been a important component of Hercules' funding strategy since 2006. This new license will enable the company to continue supporting innovative technology and life sciences companies seeking growth capital while maintaining a diversified balance sheet and favorable cost of capital. Hercules has also received exemptive relief from the SEC, allowing it to exclude SBIC leverage from applicable asset coverage limits.